Cardiac troponin T (cTnT) is a sensitive and specific pendent of comorbidity.
Patients on hemodialysis for end-stage chronic renal specific marker for myocardial damage. Asymptomatic dialysis patients have a high prevalence of cTnT concentrations above failure have a high mortality, much of it related to cardiothe diagnostic threshold for myocardial damage. There is convascular disease, including AMI. The specificity of cTnT troversy over whether this represents a false positive cTnT or in the diagnosis of AMI in hemodialysis patients and in an underlying pathology with a poor outcome. It is not known diabetes has been questioned. The first generation assay whether cTnT reflects comorbidity in these patients.
for cTnT demonstrated a very high prevalence of positive Methods. A cohort of 73 long-term hospital hemodialysis patients had cTnT estimated once prior to a mid-week dialysis.
cTnT values in these patients, in the order of 80% [3] .
Samples were analyzed using the second-generation cTnT asDespite the lack of specificity, a positive first generation say from Boehringer Mannheim on an Elecsys 1010 analyzer.
cTnT has been associated with a poor prognosis in hemo-
The standard diagnostic threshold for myocardial damage of dialysis patients [3] . The second generation assay, utilizing 0.1 ng/mL was used. A commonly employed measure of comorbidity (Khan) was applied at the time cTnT was measured.
two monoclonal antibodies, is more specific for myocardial Patients were followed for 15 months. Mortality was used as damage. Nevertheless, a proportion of hemodialysis pathe clinical end point. Kaplan-Meier survival analysis was emtients (20 to 50%) remains, with serum cTnT concentraployed and differences between groups were assessed using tion above the diagnostic cut-off point for myocardial the Cox-Mantel log-rank test. damage (0.1 ng/mL) [4 -7] . Several reports have suggested Results. Of the 73 patients, 20 were positive for cTnT and 53 were negative, at the cut-off of 0.1 ng/mL. At fifteen months, that elevated second generation cTnT is associated with 65% of the positive patients were dead, whereas only 15% of a poor prognosis [5, [8] [9] [10] [11] [12] . Other studies have failed to the negative patients were dead. Survival analysis confirmed detect such an effect [13, 14] . If there is an association that this difference was statistically significant (P Ͻ 0.00001), between cTnT and prognosis in hemodialysis patients, and that the effect of cTnT on survival was independent of it remains to be demonstrated that this is independent comorbidity.
Conclusions. There is a high prevalence of positive cTnT in of the clinical factors that are already known to influence stable hemodialysis patients. A single estimation of cTnT in survival. These include age, length of time on dialysis, the this group has significant prognostic value, independent of copresence of diabetes, ischemic heart disease, left ventricmorbidity.
ular hypertrophy, and other comorbid conditions. Various clinical scores are used to stratify hemodialysis patients according to comorbidity [15] . These are used to compare outcomes in dialysis populations. One such scoring system is that of Khan and co-workers, which has been shown to correlate with outcome ( The coefficient of inter-assay analytical variation in our a This clinical prognostic scoring system was developed by Khan et al [16] hands, at the cut-off point of 0.1 ng/mL, was Ͻ6%. Urea reduction ratio (URR) was calculated as the difference between the serum urea concentration pre-and postdialysis, divided by the serum urea pre-dialysis. prognostic index. A further aim of the study was to determine the optimal prognostic cut-off concentration of cTnT.
Statistical methods
Kaplan-Meier survival analysis was performed. Differ-METHODS ences in survival between groups were analyzed using Study design the Cox-Mantel log rank test. The Cox regression model was used to compare the predictive value of cTnT and the Survival of a group of 73 patients on long-term hospiclinical scoring system. Receiver operating characteristic tal hemodialysis was examined. The total hospital popu-(ROC) curve analysis was used to determine the cut-off lation of chronic hospital hemodialysis patients was 81.
point that maximized both sensitivity and specificity. The Blood samples suitable for the analysis of cTnT were diagnostic efficiency (true positives plus true negatives, available for 73 patients. Each patient had cTnT estidivided by total number of tests) of the test at different mated once. cTnT estimation was completed for all pacut-off points was plotted to determine the cut-off point tients within a three-day period. This study used the that correctly assigned the greatest number of patients. standard laboratory cut-off point for the diagnosis of myocardial damage of 0.1 ng/mL. Patients were followed Patients up for 15 months. Clinical details were obtained at the Patient characteristics are shown in Table 2 . end of the period by review of clinical notes by a nephrolThere was a broad range of ages and lengths of time on ogist familiar with the patients, but unaware of the cTnT renal replacement therapy (RRT). There was a male results. The patients were categorized according to the predominance. clinical prognostic scoring system of Khan and co-workers [16] , applied at the time at which the sample was RESULTS taken for cTnT (Table 1) . A subgroup analysis was performed of patients who were expected to have a higher Distribution of cTnT prevalence of cTnT. These included 12 patients with Twenty patients out of seventy-three had serum cTnT diabetes, 18 patients with symptomatic ischemic heart greater than 0.1 ng/mL. The distribution of cTnT results disease (IHD) and 23 patients with known peripheral is shown in Figure 1 . There was no significant correlation vascular disease (PVD).
between cTnT and urea reduction ratio (r ϭ Ϫ0.1033, Echocardiograms were performed as part of routine P ϭ 0.4). clinical care in 57 of the patients and were performed by Outcome a number of different technicians. Data was extracted from the clinical notes and by searching the echocardiAfter 15 months of follow-up, 21 patients had died, ography database. Assessment of left ventricular hyperleaving 52 survivors. The prevalence of cTnT greater than, trophy (LVH) and of left ventricular systolic function and less than, the cut-off point of 0.1 ng/mL and their (LVSF) was based on the interpretation of the cardiolorespective survival to 15 months is shown in Table 3 . Prevalence of positive cTnT and survival in the following gist reporting the echocardiogram.
Cox regression model
The Cox regression model was used to compare the predictive value of the comorbidity score and cTnT as binary variables, described above. It demonstrated that both variables were significant independent predictors of mortality and that the hazard ratio associated with a high risk comorbidity score was 6.7 (compared with medium and low risk combined), and the hazard ratio associated with a positive cTnT (compared with a negative cTnT) was 4.1.
Cause of death
Cause of death was established in the twenty-one who of any tendency for cTnT positive patients to have a cardiac, as opposed to a non-cardiac death. Classified as cardiac were the following deaths: two myocardial patient groups is also shown in the Table 3 : patients in the infarctions, six cardiac arrests and four cases of cardiac low-, medium-and high-risk groups, diabetic patients, failure. Classified as non-cardiac were the following deaths: four withdrawals from dialysis treatment as a patients with symptomatic ischemic heart disease and result of severe intractable comorbidity, four cases of patients with known peripheral vascular disease. In each sepsis and one malignancy. The distribution of cTnT subgroup those with a negative cTnT had a better outamong the cardiac and non-cardiac causes of death is come. The distribution of cTnT and of survival within shown in Table 5 . groups, divided according to echocardiographic findings, is shown in Table 4 point at which sensitivity and specificity were equal (at 76%) was at cTnT concentration of 0.063 ng/mL.
Survival analysis
In terms of diagnostic efficiency, the proportion of paThe Kaplan-Meier survival curve of the 73 patients, tients correctly assigned (true positives plus true negatives divided into those who were cTnT positive and negative divided by total), there was essentially no difference beis shown in Figure 2 . The difference in survival was tween cut-off points between 0.06 and 0.2 ng/mL (Fig. 7) . statistically significant (P Ͻ 0.00001, Cox-Mantel logThe Cox regression model was repeated to assess wherank test). The survival curve of the 73 patients divided ther the 0.06 ng/mL cut-off point performed better than according to the comorbidity score into three groups the 0.1 ng/mL cut-off point. This demonstrated that when (low, medium and high risk) is shown in Figure 3 . The using the 0.06 ng/mL cut-off point, the hazard ratio assodifference in survival between the groups was statistically ciated with a positive cTnT was 4.8, while the hazard ratio significant (P Ͻ 0.0001, Cox-Mantel log-rank test).
associated with a high risk score was reduced to 4.3. To make a valid comparison between cTnT and comorbidity as predictors of mortality, we expressed both DISCUSSION indices as binary variables (cTnT positive versus cTnT negative: High-risk versus medium-and low-risk groups
The high prevalence of raised cTnT in asymptomatic combined). Kaplan-Meier survival analysis was performed dialysis patients undermines the role of this marker in for the 43 patients in the combined low and medium risk the diagnosis of acute coronary syndromes in this group groups, and is shown in Figure 4 . The number of events in of patients. Cardiac troponin I has been shown to be a the low risk group was too low to allow survival analysis better predictor of acute myocardial damage than tropoaccording to cTnT status. The survival analysis for the 30 nin T, in dialysis patients who present with chest pain high risk patients is shown in Figure 5 . In both subgroups [17] . Van Lente and co-workers found that in a group cTnT was a significant predictor of mortality (P Ͻ 0.001 of renal patients (only 9% of whom were dialysis-dependent) who presented with chest pain, both cTnT and TnI and P Ͻ 0.05, respectively). All  73  20  53  71  35  85  Low risk  21  1  20  100  100  100  Medium risk  22  6  16  82  50  94  High risk  30  13  17  43  23  59  Diabetes  12  7  5  50  29  80  IHD  18  8  10  61  25  90  PVD  23  13  10  48  31  70 Abbreviations are: cTnT, cardiac troponin T; IHD, ischemic heart disease; PVD, peripheral vascular disease. predicted adverse outcomes less well than in non-renal appropriate to compare the prognostic value of cTnT patients [18] .
with comorbidity at the same time. We have demonstrated that a single estimation of Use of the Cox regression model in our study was limcTnT is a predictor of mortality in chronic hemodialysis ited to estimating the relative strength of cTnT and the patients, independent of a commonly used clinical progclinical comorbidity score in predicting death in dialysis nostic index. Khan and co-workers used their clinical patients. We did not seek to determine the best model to score at the start of dialysis. We modified the use of predict death in these patients, and thus no other biothe comorbidity score by applying it at the time of the chemical and clinical factors were included in the model. estimation of cTnT. Since cTnT was measured at a single Patients were grouped so that both the clinical score and time point, which for these patients was at varying stages in the natural history of their disease, we believed it was cTnT status would be in a binary format, so that like could be compared with like, as well as to express the A further study, which demonstrated that cTnT had outcome of the analysis in the form of hazard ratios.
no effect on prognosis in chronic renal failure, examined Previous studies have shown that cTnT is a predictor a diverse group of patients and included only 20 hemodiof mortality in dialysis patients, independent of certain alysis patients [13]. Mockel et al excluded patients with selected single diagnoses, such as diabetes or vascular symptoms of ischemic heart disease, thus selecting a lowdisease [8, 11, 19] . Those authors did not evaluate risk population. In our study, the patients in the lowest whether cTnT contributed prognostic information in adrisk group had a very favorable prognosis and a low dition to what was obtained from recognized clinical prevalence of positive cTnT concentration, making it prognostic indices. The cTnT testing protocol in the first difficult to assess whether a negative cTnT confers a of these studies was different to ours. Those authors survival advantage in this group with the lowest risk measured cTnT on three occasions and used the highest score. We noted that patients with a history of ischemic concentration, and thus had a higher prevalence of positive patients.
heart disease, but without recent symptoms suggestive of an acute coronary syndrome, who were negative for lar association between cardiac Troponin T and fatal cardiovascular events was found by Dierkes and cocTnT, had a good prognosis. We believe that these patients should be included in studies into the prognostic workers [19] . In our study, however, there did not appear to be a value of cTnT in dialysis patients.
This study demonstrated that the cut-off point of relative excess of cardiac, as opposed to non-cardiac, death among the cTnT positive patients. The cause of 0.1 ng/mL, as is used in the risk stratification of unstable angina, is a reasonable cut-off point for predicting outdeath was determined by review of case notes and no post-mortem examinations were performed. Sudden, uncome in hemodialysis patients. This cut-off point is close to the point on the ROC curve where sensitivity and expected death at home, one of the principal modes of death in these patients, was classified as cardiac arrest. specificity are maximal. It also falls within the range in which good diagnostic efficiency is obtained. Larger
This relatively crude and limited analysis should not be expected to correlate closely with detailed post-mortem studies may be required to define the cut-off point with the greatest diagnostic efficiency more precisely. The examinations.
The discrepancy between the prevalence of positive finding that diagnostic efficiency is maximal at a higher cut-off point than that determined by ROC curve analycTnT and cTnI in dialysis patients has been debated [21] . It is known that cTnI has a shorter serum half-life. It sis is a reflection of the fact that survival was, overall, a more likely outcome than death in this group. Thus, one also is known that the two epitopes on the cTnT molecule that are recognized by the current cTnT assay are very was more likely to be correct if one predicted survival rather than death. Choosing a higher cut-off point is the close together and thus make the assay quite resistant to instability on storage. Cleavage of the molecule must equivalent of predicting more survivors. Unlike analysis of diagnostic efficiency, ROC curve analysis, by emphaoccur between the two epitopes for the molecule to fail to react in the assay system. The epitopes recognized by sizing sensitivity and specificity, does not take into account the prevalence of the outcome in question.
most of the various cTnI assay systems are situated further apart on the molecule. Thus, proteolytic degradaThe fact that the 0.06 ng/mL cut-off point emerged as a better predictor using the Cox model suggests that tion products of cTnT are much more likely to be detected by the cTnT assay than are cTnI degradation the prognostic information provided by cTnT at lower concentrations is more independent of clinical markers products in the cTnI assay systems. Wu and co-workers speculate that retention of proteolytic degradation prodof comorbidity than at higher cTnT concentrations. If one is interested in using cTnT as an additional factor ucts of cTnT in dialysis patients, which are detected by the cTnT assay, may make the cTnT assay more sensitive in a panel of clinical and biochemical markers of prognosis (and if one chooses to express cTnT as a binary varito minor degrees of myocardial damage [23] . Thus, they suggest that the signal caused by minor ongoing myocarable), then the 0.06 ng/mL cut-off point would be preferable to the 0.1 ng/mL cut-off point as it contributes more dial damage is amplified in the case of cTnT in dialysis patients, but not in the case of cTnI. independent information.
The biological process underlying the increased cTnT Predicting survival in renal dialysis patients is important. When comparing clinical outcomes between differin hemodialysis patients is unclear. Several hypotheses have been proposed. It has been suggested that the skeleent renal units, as part of benchmarking exercises, it is essential to correct for the underlying comorbidity and tal myopathy associated with end-stage renal failure induces expression of the fetal isoform, which happens to for the prognosis of the patients [16] . Clinical prognostic factors have been thoroughly explored. Biochemical progbe cTnT, in replicating skeletal muscle, and that this gives rise to the false-positive cTnT result. This hypothesis has nostic factors such as C-reactive protein may add to the ability to predict outcome [24] . cTnT may, in the future, been disputed [20, 21] . It also has been suggested that the presence of left ventricular hypertrophy, silent ischemia, be included in a panel of biochemical markers used to assist in this process. The concept of rationing dialysis on and metabolic cardiomyopathy may cause this elevation of cTnT in dialysis patients. In a diverse group of patients the basis of prognosis has been opened for debate [15] .
Other treatment options may also be considered in the who underwent post-mortem examination and who included a small number of dialysis patients, antemortem light of a patient's prognosis, such as referral for revascularization procedures or renal transplantation. In our cTnT was associated with a range of abnormal myocardial histologic findings [22] . The independent association study, dialysis patients with left ventricular hypertrophy (LVH) who had a positive cardiac Troponin T had a between cTnT and death in hemodialysis patients would seem to favor a cardiac pathology. Ooi et al [11] , in much worse prognosis than similar patients with negative cTnT. This difference suggests that it might be possible contrast with their findings at twelve months of followup, found that follow-up at thirty-six months demontarget therapy aimed at inducing regression of LVH at those patients with the poorest prognosis, that is, those strated that a positive cardiac Troponin T was associated with cardiac-as opposed to non-cardiac-death. A simiwith a positive cTnT.
